Roche Holding’s (ROG) “Buy” Rating Reaffirmed at JPMorgan Chase & Co.
ROG has been the topic of several other research reports. Citigroup Inc. reissued a buy rating on shares of Roche Holding in a research report on Friday, July 1st. Goldman Sachs Group Inc. reissued a buy rating on shares of Roche Holding in a research report on Tuesday, July 19th.
Roche Holding (VTX:ROG) opened at 240.70 on Tuesday. The firm’s 50-day moving average is CHK 242.12 and its 200-day moving average is CHK 245.99. The stock has a market capitalization of CHK 205.12 billion and a P/E ratio of 22.17. Roche Holding has a 12-month low of CHK 229.90 and a 12-month high of CHK 281.40.
About Roche Holding
Roche Holding AG is a research-based healthcare company. The Company develops, manufactures and delivers medicines, and diagnostic instruments and tests. Its operating businesses are organized into two divisions: Pharmaceuticals and Diagnostics. Its Pharmaceuticals division consists of two business segments: Roche Pharmaceuticals and Chugai.
Receive News & Stock Ratings for Roche Holding Ltd. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Roche Holding Ltd. and related stocks with our FREE daily email newsletter.